Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
暂无分享,去创建一个
Ajit S. Divakaruni | Yusu Gu | N. Dalton | G. Dorn | K. Peterson | S. Miyamoto | A. Murphy | A. Zambon | B. Westenbrink | S. Matkovich | Haiyun Ling | Charles B. B. Gray | J. Heller Brown | Joan Heller Brown
[1] Inna Dubchak,et al. Whole-Genome rVISTA: a tool to determine enrichment of transcription factor binding sites in gene promoters from transcriptomic data , 2013, Bioinform..
[2] C. Indolfi,et al. Genetic Deletion of Uncoupling Protein 3 Exaggerates Apoptotic Cell Death in the Ischemic Heart Leading to Heart Failure , 2013, Journal of the American Heart Association.
[3] T. Horvath,et al. Mitochondria in Cardiovascular Physiology and Disease Role of uncoupling protein 3 in ischemia-reperfusion injury , arrhythmias , and preconditioning , 2013 .
[4] C. Chen,et al. Protective Effects of Acyl-coA Thioesterase 1 on Diabetic Heart via PPARα/PGC1α Signaling , 2012, PloS one.
[5] E. Abel,et al. UCP3 Regulates Cardiac Efficiency and Mitochondrial Coupling in High Fat–Fed Mice but Not in Leptin-Deficient Mice , 2012, Diabetes.
[6] Xiaoxue Zhang,et al. Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial Infarction*♦ , 2012, The Journal of Biological Chemistry.
[7] Mark E. Anderson,et al. CaMKII determines mitochondrial stress responses in heart , 2012, Nature.
[8] Mark E. Anderson,et al. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. , 2012, Circulation research.
[9] X. Wehrens,et al. Human Stanniocalcin-1 Suppresses Angiotensin II-Induced Superoxide Generation in Cardiomyocytes through UCP3-Mediated Anti-Oxidant Pathway , 2012, PloS one.
[10] T. Saikawa,et al. Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart. , 2012, Journal of molecular and cellular cardiology.
[11] S. Akira,et al. Mitochondrial DNA That Escapes from Autophagy Causes Inflammation and Heart Failure , 2012, Nature.
[12] Michael A. Burke,et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies , 2012, European journal of heart failure.
[13] Mark E. Anderson,et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone , 2011, Nature Medicine.
[14] Donald M Bers,et al. CaMKII in myocardial hypertrophy and heart failure. , 2011, Journal of molecular and cellular cardiology.
[15] J. Brown,et al. Crossing signals: relationships between β-adrenergic stimulation and CaMKII activation. , 2011, Heart rhythm.
[16] Niels Voigt,et al. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. , 2011, The Journal of clinical investigation.
[17] M. Brand,et al. High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria , 2011, PloS one.
[18] R. deKemp,et al. Hexokinase II acts through UCP3 to suppress mitochondrial reactive oxygen species production and maintain aerobic respiration. , 2011, The Biochemical journal.
[19] Mark E. Anderson,et al. CaMKII in the cardiovascular system: sensing redox states. , 2011, Physiological reviews.
[20] Ajit S. Divakaruni,et al. The regulation and physiology of mitochondrial proton leak. , 2011, Physiology.
[21] C. Zechner,et al. Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation , 2011, Cancer Chemotherapy and Pharmacology.
[22] S. Collins,et al. Glutathionylation Acts as a Control Switch for Uncoupling Proteins UCP2 and UCP3* , 2011, The Journal of Biological Chemistry.
[23] T. Prolla,et al. Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and G&agr;q Overexpression–Induced Heart Failure , 2011, Circulation research.
[24] M. Rogawski,et al. Seizure Protection by Intrapulmonary Delivery of Propofol Hemisuccinate , 2011, Journal of Pharmacology and Experimental Therapeutics.
[25] J. Farber,et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. , 2010, The Journal of clinical investigation.
[26] A. Newton,et al. PHLPP-1 Negatively Regulates Akt Activity and Survival in the Heart , 2010, Circulation research.
[27] Ajit S. Divakaruni,et al. The regulation and turnover of mitochondrial uncoupling proteins. , 2010, Biochimica et biophysica acta.
[28] Derek J Van Booven,et al. Deep mRNA Sequencing for In Vivo Functional Analysis of Cardiac Transcriptional Regulators: Application to G&agr;q , 2010, Circulation research.
[29] R. Chen,et al. The effects of a PPARalpha agonist on myocardial damage in obese diabetic mice with heart failure. , 2010, International heart journal.
[30] N. Dalton,et al. Phospholamban Ablation Rescues Sarcoplasmic Reticulum Ca2+ Handling but Exacerbates Cardiac Dysfunction in CaMKII&dgr;C Transgenic Mice , 2010, Circulation research.
[31] M. MacCoss,et al. Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging , 2009, Circulation.
[32] Tong Zhang,et al. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. , 2009, The Journal of clinical investigation.
[33] Hugo A. Katus,et al. The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload , 2009, Proceedings of the National Academy of Sciences.
[34] M. Emond,et al. Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.
[35] Mark E. Anderson,et al. A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation , 2008, Cell.
[36] G. Dorn,et al. Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive Heart Failure by Estrogen , 2007, Circulation.
[37] G. Dorn. The Fuzzy Logic of Physiological Cardiac Hypertrophy , 2007, Hypertension.
[38] T. Kato,et al. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. , 2006, Journal of molecular and cellular cardiology.
[39] Guy Salama,et al. Calmodulin kinase II inhibition protects against structural heart disease , 2005, Nature Medicine.
[40] E. Olson,et al. Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.
[41] Tong Zhang,et al. The &dgr;C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure , 2003, Circulation research.
[42] K. Chien,et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes , 2001, Nature Medicine.
[43] G. Dorn,et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .
[44] K. Chien,et al. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. , 1993, The Journal of biological chemistry.
[45] W. Kannel,et al. Precursors of sudden coronary death. Factors related to the incidence of sudden death. , 1975, Circulation.
[46] M. Gheorghiade,et al. Enhancing the metabolic substrate: PPAR-alpha agonists in heart failure , 2010, Heart Failure Reviews.
[47] W. Koch,et al. Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress , 2002, Circulation.
[48] K. Chien,et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. , 2001, Nature medicine.
[49] G. Dorn,et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] D E Manyari,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.